Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples